ArticleEuropean heart journal. Case reports2025
Incidental apical left ventricular mural thrombus late after myocardial infarction with chronic myeloid leukaemia detected by cardiac magnetic resonance: a case report.
Article in European heart journal. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Left ventricular (LV) thrombus represents a critical complication following acute myocardial infarction (MI), particularly in patients with reduced LV ejection fraction (LVEF) < 40%, extensive MI, and LV aneurysm. Chronic myeloid leukaemia (CML), a haematological malignancy, is a recognized risk factor for thrombosis. While transthoracic echocardiography (TTE) serves as a 'goalkeeper' for the initial screening modality, its sensitivity in detecting mural thrombi remains limited. Cardiac magnetic resonance (CMR) with gadolinium enhancement has emerged as the diagnostic gold standard due to its superior spatial resolution and ability to recognize thrombus. Case summary: A 47-year-old male with CML, undergoing chemotherapy and a history of extensive anterior ST elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (PCI) of the proximal left anterior descending (LAD) coronary artery, presented with exertional dyspnoea. Although serial non-contrast TTEs over 12 months revealed reduced left ventricular ejection fraction (LVEF) and extensive regional wall motion abnormalities, with pulmonary hypertension (PASP 46 mmHg), no thrombus was detected. Contrast-enhanced CMR identified a large transmural MI involving the anterior, anterolateral walls, and apex with an apical LV mural thrombus. After 3 months of warfarin therapy, the thrombus reduced in size and showed no improvement in LV systolic function (LVEF 36%). Conclusion: CMR is superior to non-contrast TTE in detecting and monitoring LV thrombus treatment. The early CMR should be considered in high-risk patients post MI, particularly in those with concomitant haematological malignancy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.